Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intellia Therapeutics (NTLA) Shares Issued (2017 - 2025)

Intellia Therapeutics (NTLA) has disclosed Shares Issued for 9 consecutive years, with $1.4 million as the latest value for Q4 2025.

  • Quarterly Shares Issued fell 99.23% to $1.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $16.3 million through Dec 2025, down 90.79% year-over-year, with the annual reading at $2.6 million for FY2025, 98.54% down from the prior year.
  • Shares Issued for Q4 2025 was $1.4 million at Intellia Therapeutics, up from $1.2 million in the prior quarter.
  • The five-year high for Shares Issued was $1.8 billion in Q3 2021, with the low at -$386.7 million in Q2 2022.
  • Average Shares Issued over 5 years is $220.0 million, with a median of $2.0 million recorded in 2024.
  • The sharpest move saw Shares Issued skyrocketed 13368.75% in 2021, then crashed 162.15% in 2024.
  • Over 5 years, Shares Issued stood at $1.8 billion in 2021, then crashed by 78.74% to $386.0 million in 2022, then plummeted by 69.5% to $117.7 million in 2023, then skyrocketed by 48.82% to $175.2 million in 2024, then crashed by 99.23% to $1.4 million in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at $1.4 million, $1.2 million, and $13.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.